Pharmaceutical composition for treating endometritis as well as preparation method and application thereof

A technology of endometritis and composition, applied in the field of traditional Chinese medicine composition, can solve the problems of high cost, poor drug effect, unfavorable treatment, etc.

Pending Publication Date: 2022-07-15
HEBEI GREENLAND ANIMAL PHARMA CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For metritis in females, the main clinical treatment is chemical drugs, which are not only expensive and cumbersome, but also easily cause antibiotic residues, which in turn lead to drug resistance, which is not conducive to subsequent treatment
[0004] Although t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] A pharmaceutical composition for treating endometritis, comprising the following components in parts by weight: 15 parts Motherwort, 20 parts Evodia, 10 parts Angelica sinensis, 5 parts Panax notoginseng and 16 parts medical starch.

[0027] The preparation method of the above-mentioned pharmaceutical composition for treating endometritis is as follows: mixing the above-mentioned motherwort, evodius root, angelica and Panax notoginseng in parts by weight, smashing through a 100-mesh sieve, adding medical starch and mixing for 1 hour.

[0028] The above-mentioned pharmaceutical composition for treating endometritis is granulated and tableted to obtain a tablet, and the dosage of the tablet is 5g / tablet.

Embodiment 2

[0030] A pharmaceutical composition for treating endometritis, comprising the following components in parts by weight: 18 parts of Motherwort, 22 parts of Evodia, 12 parts of Angelica sinensis, 6 parts of Panax notoginseng and 18 parts of medical starch.

[0031] The preparation method of the above-mentioned pharmaceutical composition for treating endometritis is as follows: mixing the above-mentioned motherwort, evodius root, angelica and Panax notoginseng in parts by weight, smashing through a 100-mesh sieve, adding medical starch and mixing for 1 hour.

[0032] The above-mentioned pharmaceutical composition for treating endometritis is granulated and tableted to obtain a tablet, and the dosage of the tablet is 5g / tablet.

Embodiment 3

[0034] A pharmaceutical composition for treating endometritis, comprising the following components in parts by weight: 12 parts Motherwort, 18 parts Evodia, 8 parts Angelica sinensis, 4 parts Panax notoginseng and 15 parts medical starch.

[0035] The preparation method of the above-mentioned pharmaceutical composition for treating endometritis is as follows: mixing the above-mentioned motherwort, evodius root, angelica and Panax notoginseng in parts by weight, smashing through a 100-mesh sieve, adding medical starch and mixing for 1 hour.

[0036] The above-mentioned pharmaceutical composition for treating endometritis is granulated and tableted to obtain a tablet, and the dosage of the tablet is 5g / tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of traditional Chinese medicine compositions, and particularly discloses a pharmaceutical composition for treating endometritis and a preparation method and application thereof. The pharmaceutical composition for treating endometritis is prepared from the following components in parts by weight: 10 to 20 parts of herba leonuri, 15 to 25 parts of fructus evodiae, 5 to 15 parts of radix angelicae sinensis, 3 to 7 parts of radix notoginseng and 10 to 20 parts of auxiliary materials. The pharmaceutical composition for treating endometritis provided by the invention has the effects of removing necrotic tissue, promoting granulation, dispersing blood stasis and clearing heat, can effectively improve the symptoms of postpartum low fever, endless lochia and long-term infertility of female animals when being used for treating the endometritis of the female animals, and can achieve higher cure rate by once medication. Meanwhile, the pharmaceutical composition is simple in component, low in dosage and free of adverse reaction.

Description

technical field [0001] The present invention relates to the technical field of traditional Chinese medicine compositions, in particular to a medicinal composition for treating endometritis and a preparation method and application thereof. Background technique [0002] Endometritis is a common and frequently-occurring disease in female animals such as pigs, cattle and sheep. It mostly occurs after the female animals give birth. Although the mortality rate is very low, the incidence rate is high, which seriously affects the fertility and production performance of female animals. [0003] With the continuous development of the current livestock breeding volume and breeding scale, the incidence of animal endometritis has shown a clear upward trend, and female animals such as pigs, cattle, and sheep are not in heat, infertility, and miscarriage. great loss. For female metritis, the main clinical treatment is chemical medicine, which is not only expensive and cumbersome, but also...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/754A61K9/20A61P15/00A61P15/08
CPCA61K36/533A61K36/754A61K36/232A61K36/258A61K9/2059A61K9/0034A61P15/00A61P15/08A61K2300/00
Inventor 杜西翠王梦雪张趁刘格格郭艳钦李泽庭武珊杨丽杰
Owner HEBEI GREENLAND ANIMAL PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap